Experimental evidence of a potentially increased thrombo-embolic disease risk by domestic electromagnetic field exposure

Bioelectromagnetics. 2004 May;25(4):313-5. doi: 10.1002/bem.20022.

Abstract

We have used the EaHy926 endothelial cell line, able to secrete both pro and anti-aggregant platelet agents, as a model for thrombo-embolic diseases. We experimentally established, by comparing these two secretions with or without a Faraday cage, that the environmental electromagnetic field significantly increases the thrombo-embolic risks in this endothelial cell line.

MeSH terms

  • 6-Ketoprostaglandin F1 alpha / metabolism
  • Cell Line
  • Electromagnetic Fields / adverse effects*
  • Endothelium, Vascular / metabolism
  • Endothelium, Vascular / radiation effects
  • Enzyme-Linked Immunosorbent Assay
  • Epoprostenol / metabolism
  • Humans
  • Risk Factors
  • Thromboembolism / etiology*
  • Thromboxane A2 / metabolism
  • Thromboxane B2 / metabolism

Substances

  • Thromboxane B2
  • Thromboxane A2
  • 6-Ketoprostaglandin F1 alpha
  • Epoprostenol